EFFICIENCY OF THERAPY FOR HYPERTENSION UNDER THE CONDITIONS OF THE FAR NORTH

Download full text PDF
Issue: 
1
Year: 
2016

I. Zapesochnaya, Candidate of Medical Sciences; Professor A. Avtandilov, MD Russian Medical Academy of Postgraduate Education, Moscow

The impact of combined therapy with amlodipine and ramipril on the structural and functional status of the myocardium and the diastolic function of the left ventricle was evaluated in hypertensive patients under the conditions of the Far North.
Keywords: 
amlodipine
hypertension
ramipril
left ventricular hypertrophy
diastolic function

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Zhitnikova L.M. Arterial'naja gipertonija: kurs na effektivnoe kom- binirovannoe lechenie // Rus. med. zhurn. – 2011; 26: 25–8.
  2. Sumin A.N., Barbarash O.L. Aktual'nye voprosy lechenija arterial' noj gipertenzii (po materialam evropejskih kongressov, 2010) // Kardiologija. – 2012; 5: 88–96.
  3. Roger V., Go A., Lloyd-Jones D. et al. Heart disease and stroke statistics 2011 update: a report from the American Heart Association // Circulation. – 2011; 123 (4): 18–209.
  4. Erbel R., Lehmann N., M4. öhlenkamp S. et al. Subclinical coronary atherosclerosis predicts cardiovascular risk in different stages of hypertension: result of the heinz nixdorf recall study // Hypertension. – 2012; 59 (1): 44–53.
  5. Sorokin E.V., Karpov Ju.A. Kombinirovannaja antigipertenzivnaja tera pija – kljuch k povysheniju effektivnosti serdechno-sosudistoj profilakti-ki // Rus. med. zhurn. – 2012; 25: 91–100.
  6. Gradman A., Basile J., Carter B. et al. Combination therapy in hypertension // J. Am. Soc. Hypertens. – 2010; 4: 42–50.
  7. Chazova I.E., Ratova L.G., Bojtsov S.A. Diagnostika i lechenie arterial' noj gipertenzii. Rekomendatsii Rossijskogo meditsinskogo obschestva po arterial'noj gipertonii i Vserossijskogo nauchnogo obschestva kardiologov // Sistemnye gipertenzii. – 2010; 3: 5–27.
  8. Karpov Ju.A. Kombinirovannaja antigipertenzivnaja terapija – priori-8. tetnoe napravlenie v lechenii arterial'noj gipertonii // Rus. med. zhurn. – 2011; 26: 35–41.
  9. Katholi R., Couri D. Int Left ventricular hypertrophy major risk factor in 9. patients with hypertension; update and practical clinical application // J. Hypertension. – 2011; 495349.
  10. Saeder M., Kaye D. Heart failure with normal left ventricular ejection fraction // J. Am. Coll. Cardiol. – 2009; 53: 905–18
  11. Tatarchenko I.P., Pozdnjakova N.V., Morozova O.I. i dr. Diastolicheskaja disfunktsija levogo zheludochka pri ishemicheskoj bolezni serdtsa (patofizi-ologicheskie, klinicheskie i instrumental'nye aspekty, optimizatsija tera-pii) / Penza: Izd-vo Penz. in-ta ekonom. razvitija i antikrizis. upr., 2009; 142 s.
  12. Hasnulin V.I., Hasnulina A.V., Chechetkina I.I. Severnyj stress, for- mirovanie arterial'noj gipertenzii na Severe, podhody k profilaktike i lecheniju // Ekologija cheloveka. – 2009; 6: 26–30.
  13. Panin L.E. Gomeostaz i problemy pripoljarnoj meditsiny (metodolo gicheskie aspekty adaptatsii) // Bjul. SO RAMN. – 2010; 3 (3): 6–11.
  14. Belisheva N.K., Talykova L.V., Mel'nik N.A. Vklad vysokoshirotnyh geliogeograficheskih agentov v kartinu zabolevaemosti naselenija Murmanskoj oblasti // Izvestija Samarskogo nauchnogo tsentra RAN. – 2011; 13: 1 (8): 1831–6.
  15. Gapon L.I., Shurkevich N.P., Vetoshkin A.S. Strukturnye izmenenija 15. miokarda pri razlichnom sutochnom profile arterial'nogo davlenija u bol'-nyh arterial'noj gipertoniej v uslovijah ekspeditsionnoj vahty na Krajnem Severe // Kardiologija. – 2005; 1 (45): 51–6.
  16. Dzherieva I.S., Volkova N.I., Rapoport S.I. Smennaja rabota kak odin 16. iz faktorov riska razvitija arterial'noj gipertenzii i metabolicheskih narushenij // Rats. farmakoter. v kardiol. – 2012; 8 (2): 185–9.
  17. Jamerson K., Weber M., Bakris G. et al. On behalf of the ACCOMPLISH 17. investigators. Benazepril plus amlodipine or hydrochlorotiazide for hypertension in high-risk patients // N. Engl. J. Med. – 2008; 359: 2417–28.
  18. Bertrand M., Ferrari R., Remme W. et al. On behalf of the EUROPA 18. Investigators. Synergistic effect of perindopril and calcium channel blockers in revention of cardiac events and death in coronary artery disease patients: analysis from the EUROPA study // Am. Heart J. – 2010; 159: 795–802.
  19. Chazova I.E., Martynjuk T.V., Ratova L.G. V fokuse vnimanija – ingibi-19. tory angiotenzinprevraschajuschego fermenta: ramipril pri arterial'noj gipertonii // Sistemnye gipertenzii. – 2011; 3: 5–10.
  20. Yusuf S., Sleight P., Pogue J. et al. The Heart Outcomes Prevention 20. Evaluation Study Investigators. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high risk patients // N. Engl. J. Med. – 2000; 342: 145–53.
  21. Rabochaja gruppa po lecheniju arterial'noj gipertonii Evropejskogo 21. obschestva gipertonii i Evropejskogo obschestva kardiologov. Rekomendatsii po lecheniju arterial'noj gipertonii // Ros. kardiol. zhurn. – 2014; 1 (105): 7–94.
  22. Mitchell G., Hwang S., Vasan R. et al. Arterial stiffness and cardiovascular 22. events: the Framingham Heart Study // Circulation. – 2011; 4: 505–11.